Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
about
A2 gene of Old World cutaneous Leishmania is a single highly conserved functional gene.Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapyAntigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral LeishmaniasisAdaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective responseIdentification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approachClinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigenIdentification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasitesEpitope mapping of recombinant Leishmania donovani virulence factor A2 (recLdVFA2) and canine leishmaniasis diagnosis using a derived synthetic bi-epitope.Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasisAntigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.Sequencing and Gene Expression Analysis of Leishmania tropica LACK GeneA Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against LeishmaniaGlycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host.Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine.The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB/c mice against experimental L. amazonensis infectionSensitive and specific serodiagnosis of Leishmania infantum infection in dogs by using peptides selected from hypothetical proteins identified by an immunoproteomic approachMulticomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.Strychnos pseudoquina and Its Purified Compounds Present an Effective In Vitro Antileishmanial ActivityCross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune Responses1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.Annexin A1 Is Involved in the Resolution of Inflammatory Responses during Leishmania braziliensis Infection.Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis.Antileishmanial activity of compounds produced by endophytic fungi derived from medicinal plant Vernonia polyanthes and their potential as source of bioactive substances.Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis.An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients.A recombinant chimeric protein composed of human and mice-specific CD4+ and CD8+ T-cell epitopes protects against visceral leishmaniasis.Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis.Proteoliposomes in nanobiotechnology.Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice.Pretreatment of Mesenchymal Stem Cells With Leishmania major Soluble Antigens Induce Anti-Inflammatory Properties in Mouse Peritoneal Macrophages.Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.
P2860
Q24811684-6C80CCC4-1EF2-4CC1-A41A-C531841CFB14Q26796580-17067D05-47E9-4ECD-9417-32003E82A12AQ27318412-94052E22-52D2-4AC2-BE32-D490D6A4D56FQ28476049-0C4266A5-6E86-4DD5-980C-9D00E78A427FQ28478933-25AE6CCD-0A01-4942-BAAC-A3B98B9869FEQ28539852-53418741-7B50-4167-A3B4-C429AE1301E4Q31155717-EC1D2945-3325-485A-A501-AF433F97F1F3Q33783739-8E4A9950-89AB-4F80-8039-F3AC46AF46ACQ34344080-5D131EFE-2093-4964-9733-3EC26CE9B2C1Q34347500-547B0138-7513-4C88-873B-0AD453386365Q34565059-E01EF5A8-42BD-4CB9-83C6-791E4264B5FDQ34662190-BD63329A-D60E-488E-978F-ACB831E41838Q35133229-782EA308-A5B3-4181-A340-8DF8DACD72E4Q35687444-AB61492D-4680-4C9D-A25A-7053264EF648Q36211636-9DCD4731-A03D-47FE-94DF-EEF5EC9A2D7AQ36251325-EB2D7DE0-C72D-4A0F-B603-036A8A043477Q36281325-E5832C32-96EF-4F6D-9512-F87CF76B8B04Q36415941-3436A71D-186B-426C-ACB4-D8648366BB7CQ36528643-6DA24415-385F-47B4-9806-C47B1200FB64Q36911295-53D2C50B-2473-466E-B1C6-D3E5961ECE52Q37220949-B17978BC-7F0F-4E3F-9ADC-74D5DEDF6628Q37249872-BD30A1C6-D396-4D85-B400-7D837A595F95Q37434214-3FADFA64-2827-47A5-9904-FC5C1D93F2BFQ37597619-D205332D-8A30-4C33-A431-8E5DBF4FB2A6Q37681093-CC5202E4-5217-44A8-BDF6-13ACB739593EQ38673741-8A536988-6FA5-4D0B-A5D9-F0770A29D159Q38702247-2A96D2AF-320B-4F83-AD44-676F572831F8Q38910414-E93C38DA-3556-4B45-B1EB-571D1494BA20Q38947177-EF867C13-3B2F-46B3-B59D-BEF3D41C93F3Q38974656-D7824CB7-7A07-4BD7-ADDF-287ACFB3847BQ39156593-E4454835-B3B9-4A6E-8E28-884261427370Q39156596-EB83EDE2-DD3D-4EB6-96CB-94119E892683Q39156601-6AFB6DDB-6B48-47DC-B39F-9842BECBA602Q39180422-03FB6E33-F10C-4672-9530-AD15745DE214Q39220181-1132C6E7-8E16-47CE-AD04-10FBE3305B66Q39220191-C423DC86-EF2E-4B46-A2DB-D5190C7E2598Q39310225-F3E9CD8E-AC41-46F9-9D84-357DC89C16BCQ40105761-0319FCAC-990C-4453-91A5-DFD5DEAA686CQ40340777-7A7DCA07-F498-45F3-99E4-CADE37CB4D48Q40794947-590E9CF8-BDC2-49CC-8B11-645F689286BA
P2860
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immune responses induced by th ...... hmania) amazonensis infection.
@ast
Immune responses induced by th ...... hmania) amazonensis infection.
@en
type
label
Immune responses induced by th ...... hmania) amazonensis infection.
@ast
Immune responses induced by th ...... hmania) amazonensis infection.
@en
prefLabel
Immune responses induced by th ...... hmania) amazonensis infection.
@ast
Immune responses induced by th ...... hmania) amazonensis infection.
@en
P2093
P2860
P1476
Immune responses induced by th ...... shmania) amazonensis infection
@en
P2093
Ana Paula Fernandes
Carlos Alberto Pereira Tavares
Eduardo Antonio Ferraz Coelho
Fernando Aécio Amorim Carvalho
Greg Matlashewski
Kadima Nayara Teixeira
Karina Figueiredo Chaves
Rafaela Chitarra Rodrigues
P2860
P304
P356
10.1128/IAI.71.7.3988-3994.2003
P407
P577
2003-07-01T00:00:00Z